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Abstract 
Many countries in the world have adopted genetically modified organisms as products that can have great 
beneficial impact on agriculture, industry and trade. However, to date for the whole of Africa, only South Africa 
has commercialized genetically modified organisms (GMOs). Realizing the high transactions costs—particularly 
in trade that may underlie different countries having varying policy stances on biotechnology, COMESA 
(COMESA—Common Market for Eastern and Southern Africa, is a regional grouping of 20 countries. In the context of this 
study, Tanzania is also included although it is not a COMESA member. This is because it belongs to the Association for 
Strengthening Agricultural Research in Eastern and Central Africa (ASARECA) of which nine countries are in COMESA. 
ASARECA was an active partner in this process together with ACTS—African Centre for Technology Studies and PBS—
Program on Biosafety) in collaboration with a number of partners embarked on a process of shaping a regional 
consensus on biotechnology policy for their 20 countries between 2004 and 2006 and adopted it in principle by 
the end of May 2006. Based on case studies of six countries—Egypt, Kenya, Ethiopia, Tanzania, Uganda and 
Zambia, this paper, summarizes the analysis of projected farm income gains in the region from 
commercialization of Bt maize and Bt cotton; provides an analysis of commercial export risks from approval of 
GMOs and states the position of COMESA countries on GMOs to date. Using quite conservative methods, 
projected net income gains from GMOs remain significant with over US $ 25 net benefit per hectare. As regards 
commercial export risks  to Europe from GMOs, the analysis suggests that except for Egypt, countries need not 
fear significant export losses if they make a decision to plant any of the GM commodities currently on the 
market.  
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Introduction 
The term “GMO” stands for “genetically modified 
organism.”  It is a term used to identify organisms 
such as agricultural plants that have had their DNA 
modified using a process called “genetic engineering.”  
The production of GM crops globally has increased 
50-fold, from 1.7 million hectares in 1996 to 90 
million in 2005 (Paarlberg 2006). GM crops were 
grown by approximately 8.5 million farmers in 21 
countries in 2005, up from 8.25 million farmers in 17 
countries in 2004 (Clive, 2004).  
Although currently there are eight crops (maize, 
cotton, canola, soybean, tomato, Irish potatoes, papaya 
and rape) that are now commercialized around the 
world, In Africa, only South Africa is growing GM 
crops commercially, To date, Egypt, Kenya and 
Burkina Faso are testing GM crops. 
Objectives of this Paper 
The three key objectives are: (1) to estimate the 
impacts of GMO crops on farm incomes for maize and 
cotton (2) to estimate the possible commercial exports 
risks associated with planting of GMO crops in the 
COMESA region (3) to summarize the developments 
to date in developing a regional policy on GMOs for 
COMESA countries.  
Methodology and Assumptions in Estimating Potential 
Farm Income Gains from Bt maize and Bt cotton 
The method used here begins with an examination of 
the actual harvested area of maize/cotton in each study 
country. Data on harvested maize/cotton areas are 
available from the Food and Agriculture Organization 
(FAO) of the United Nations. We then estimate the 
share of this maize/cotton area that is currently planted 
to improved varieties of maize/cotton, including 
hybrids and improved openly pollinated varieties 
(OPVs) for the sake of maize. We assume it will be 
this area currently planted to improved varieties that Economics of Biotechnology 
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will first switch to Bt. The percentage of this improved 
seed area likely to switch to Bt will then depend 
largely on the income constraints that seed-buying 
farmers currently face from stalk borer pests, the pests 
the Bt maize/cotton is intended to resist. We assume 
here that where stalk borers/boll worms are a primary 
farm production and farm income constraint for these 
farmers, roughly 40 percent of the maize/cotton area 
currently planted to improved varieties will switch to 
Bt varieties within 5-10 years. If the stalk borer /boll 
worm constraint is only secondary, we assume only a 
20 percent switch to Bt. If the stalk borer/boll worm 
constraint is small compared to the many other farm 
income constraints faced by these farmers, we assume 
only a 10 percent adoption rate on this acreage 
currently planted to improved varieties. Once we have  
used this method to project the total area on which Bt 
maize/cotton is likely to be grown, we then bring in 
evidence of income gains per hectare that have been 
recorded in other countries from switching to Bt. This 
will allow at least a crude estimate of total income 
gains to be expected in the six study countries from 
commercializing Bt maize/cotton. 
Data and Analysis 
We have refrained from over promising farm income 
benefits. With these conservative methods, projected 
farm income gains remain significant. Moreover, these 
are only estimates of short term duration—5 to 10 
years. But certainly, beyond 10 years the adoption 





Table 1. Projected annual net farm income from commercialization of Bt maize 
 Total  Share  of    Salienc
e of  













area that would 
switch to Bt 
maize in 5-10  







       years    from  swit-ching 
to Bt maize  
Bt maize  
Egypt   830,000 
ha.  
90% of maize 
area hybrid 
seeds.  
Primary   36 % of total 
(298,800 ha.)  
$25/ha.   $7.5 million  
  1 , 4 0 9 , 
5 1 5 ha.  





3% of total 
(42,285 ha.)  
$25/ha.   $1.1 million  
Kenya   1 , 6 6 4 , 
7 4 6 ha.  





14% of total 
(233,064 ha.)  
$25/ha.   $5.8 million  
  1 , 5 8 0 , 
0 0 0 ha.  
24% of maize 
area improved 
seeds  
Primary    10% of total 
(158,000 ha.)  
$25/ha.   $4.0 million  
 750,000 
ha.  





4% of total 
(30,000 ha.)  
$25/ha.   $0.8 million  
 750,000 
ha.  





15% of total 
(112,500 ha.)  
$25/ha.   $2.8 million  
Source: Paarlberg, R. et al, RABESA Report No.1 ACTS 2006 Minde and Mazvimavi  
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In Kenya for example, De Groote at al (2002) reports a 
loss of 13.5% due to stem borers valued at between 
US$25million and US$59.8million.   
Export Risks 
Export values of these commodities to various 
destinations were used to calculate potential risks 
under different scenarios. Because of erratic nature of 
some of the exports such as maize, average export 
values over a period of three years were calculated 
whenever large variations were detected. The export 
values are expressed as a percentage of total 
agricultural exports to the same destination in order to 
compute the magnitude of risk. A >2% proportion has 
been used in all cases as a measure of risk exposure 
The analysis assessed four scenarios of potential 
export risks namely; Scenario I: Probable Scenario – 
Exports to EU; Scenario II: Unlikely scenario – 
Exports to EU of all possibly GMO tainted 
commodities; Scenario III: Unlikely Scenario-exports 
in the context of intra-regional trade for all 
commodities that could be GMO tainted; Scenario IV: 
Worst case/Unlikely Scenario – Global exports. 
The results of the analysis under the four scenarios are 
presented in Tables 3-5. From the above analyses, 
under scenario 1 there is no  
 
risk exposure to any country of the region. Under   
scenario II Egypt faces a risk of 5.42%. Under 
scenario III, only Kenya and Egypt do not have 
significant risk exposures while Tanzania has the 
highest at 11.3% followed by Uganda at 5.5%. Under 
scenario IV, all countries except Kenya and Egypt face 
a risk of >2%--but this is considered the most unlikely 
scenario. Therefore, the magnitude of risk associated 
with exports to the EU appears to be relatively low 
Toward a Regional Biotechnology (GM) Policy 
COMESA, the largest economic trading bloc in Africa 
is confronted with a formidable challenge of 
reconciling trade and biotechnology/bio-safety 
developments. Regardless of individual nations 
positions, when some countries go forward with 
commercializing GMOs and others no, the region will 
become a patchwork of variable laws and regulations 
on GMOs. Even countries approving GMOs may have 
differing regulations and actual approved GM 
varieties. Trade problems may arise when countries 
have different regulations regarding the testing and 
approval procedures necessary to place GMOs and 
their products on the market or when they disagree 
about labelling and identification requirements. These 
conditions will pose critical challenges for the  
Table 2. Projected net annual farm income gains from commercialization of Bt cotton 




Share of cotton 










area that would 
switch to Bt 
cotton in 5-10 
years 
Estimate of net 
income, gain 
per ha from 
switching to Bt 
cotton (USD 
per ha) 
Total annual net farm income 
gain estimated 5-10 years 
after commercialization of Bt 
cotton (million USD) 
Egypt 315,000 100  Primary  60% of total 
(189,000 ha) 
50 9.45 
Ethiopia  64,000  72  Primary  43% of total 
(27,500 ha) 
50 1.37 
Kanya 20,000  17  Secondary  5% of total 
(1,000ha) 
50 .05 
Tanzania  420,000  25  Primary  15% of total 
(63,000 ha) 
50 3.15 
Uganda 250,000  25  Primary  36% of total 
(19,800 ha) 
50 1.88 
Zambia 55,000  60  Primary      .99 
Source: Paarlberg, R. et al, RABESA Report No.2 ACTS 2006 Economics of Biotechnology 















Table 3. Scenario I: Probable Scenario – Exports to EU 
Country  Value of total agriculture 
exports to Europe (US$ 
million) 
Value of maize exports to 
Europe (US$) 
Proportion of maize exports to total 
agricultural exports Europe (%) 
Egypt 938  58,750  0.01 
Ethiopia 450  0  0 
Kenya 1291  2,059  0 
Tanzania 408  19,052  0.005 
Uganda 116  1,023  0.001 
Zambia 119  0  0 
Other 2753  33,359  0.001 
Source: Paarlberg R. et al, RABESA Report No. 3,  2006 
Table 4. Scenario II: Unlikely scenario – Exports to EU of all possibly GMO tainted commodities 
Country  Value of total agriculture 
exports to Europe (US$ 
million) 
Value of exports to EU that may 
be shunned as GMO tainted 
(US$ million) 
Proportion of exports that may 
shunned to total agricultural 
exports (%) 
Egypt 938  50.8  5.42 
Ethiopia 450  0.045  0.01 
Kenya 1291  0.456  0.04 
Tanzania 408  1.4  0.34 
Uganda 116  0.067  0.06 
Zambia* 119  0.728  0.61 
Other 2753  4.517  0.16 
Source: Source: Paarlberg R. et al, RABESA Report No. 3,  2006. 
Table 5. Scenario III: Exports in the context of intra-regional trade of all commodities that could be tainted as GMO 
Country  Total Exports to COMESA 
(US$ m) 
Of which can be shunned 
(US$ m) 
Proportion of total exports 
to region  (%) 
Kenya 850  6  0.7 
Uganda 147.8  9  5.5 
Tanzania 186.4  21  11.3 
Zambia 350.8  18  5.2 
Egypt 372  1  0.3 
Ethiopia 58.4  1  2.1 
Other COMESA countries  396.9  21  5.2 
Source: Paarlberg R. et al, RABESA Report No.3 2006 Minde and Mazvimavi  
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COMESA countries in terms of trade in specific 
commodities within the region, let alone outside the 
continent.  
The divergence of national policies in the region 
inspired efforts to consider closer regional policy 
coordination. When considering issues of GM trade 
and biosafety, the potential benefit of greater policy 
harmonization among the countries in region is 
obvious.  
If one country in the region approved the commercial 
planting of a GMO crop before a neighboring country 
had done so, the chance arose that routine formal or 
informal cross-border would begin to bring viable 
GM-seeds from the approving country into the 
neighboring country that had not yet given planting 
approval. Taking cognizance of the current and 
anticipated challenges, efforts directed towards 
establishing a common policy on biotechnology and 
bio-safety in the COMESA region were set in motion 
in 2004 and in May 2006, a representation of member 
states from COMESA meeting in Nairobi, Kenya 
agreed that the movement of GMOs in the region is an 
inescapable fact and hence agreed on a regional 
protocol on how GMOs will be managed and 
administered. 
Conclusions 
Net farm income gains by smallholder farmers from 
the use of GM seed maize and cotton are evident. 
Conservative estimates have shown net farm income 
gains per country of up to US $ 58 million for maize 
and US $ 9 million for cotton. Commercial export 
risks to Europe emanating from production and 
exports of GM crops that are now commercially 
available are negligible. In fact, countries of the region 
should be more concerned with having a harmonized 
regional policy on GMOs because intra-regional 
exports on the available GM crops are by far larger 
compared with exports to Europe.  Individual nation’s 
positions on GMOs--with some countries going 
forward with commercializing GMOs and others not, 
will seriously stifle intra-regional trade for these  
commodities. 
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